Skip to content

Role of Health Education in the Semipresential Logopedic Treatment of the Patient With Oropharyngeal Dysphagia

Role of Health Education in the Semipresential Logopedic Treatment of the Patient With Oropharyngeal Dysphagia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04959877
Acronym
EDU-DIS
Enrollment
20
Registered
2021-07-13
Start date
2021-06-08
Completion date
2022-04-30
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia

Brief summary

When reviewing the literature, the need to investigate the health education of patients with dysphagia and their family members / caregivers has been detected. Numerous articles mention or it can be inferred from them that an education or training has been carried out for the patient and caregivers, but the investigators have not found any that specifically focuses on this aspect of the intervention. Only in some Clinical Practice Guidelines is the need for health education included

Interventions

BEHAVIORALhealth education

data collect / Telemedicine

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* People between 18 and 99 years old diagnosed by videofluoroscopy of oropharyngeal dysphagia and who are candidates for speech therapy treatment for this reason. * Knowledge of the language sufficient to understand the audiovisual material on health education available at: logopediasantpau.wordpress.com * Have the necessary technological tools to carry out the telematic processing (electronic device with Internet access and WhatsApp) and know how to use them or have a family member / direct caregiver with basic technological skills. * Signature of the informed consent

Exclusion criteria

* Moderate or severe cognitive impairment already known from the medical history or evaluated with the MoCA test in the absence of a family member or caregiver. * Having undergone speech therapy treatment for oropharyngeal dysphagia in the last year. * Not signing the informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Dysphagia Severity Rating Scaleup to 1 yearScale assessment by MBS ( 1 Non Oral - 7 Full oral intake)
Functional oral intake scaleup to 1 yearScale assessment (1nothing by mouth - 7 full oral intake)
Penetration Aspiration Scaleup to 1 yearScale Assessment by MBS (1 No airway penetration - 8 Airway aspiration, no cough)
Bolus Residual Scaleup to 1 yearScale Assessment by MBS (1 No residues - 6 Residue in Valleculae and posterior Pharyngeal wall and piriform sinus)

Secondary

MeasureTime frameDescription
SwalQOLUp to 1 yearQuality of life related to oropharyngeal dysphagia (11 Domains)

Countries

Spain

Contacts

Primary ContactHelena Bascuñana Ambros, MD, PhD
hbascunana@santpau.cat932919000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026